La ligne téléphonique n’est pas disponible pour le moment.Pour toute demande veuillez envoyer un email a support@advfn.fr

Amended Statement of Beneficial Ownership (3/a)

Date : 08/05/2019 @ 01h41
Source : Edgar (US Regulatory)
Valeur : Merck & Company (New) (MRK)
Cours : 85.24  -0.27 (-0.32%) @ 23h50
Merck Cours Graphique

Amended Statement of Beneficial Ownership (3/a)

FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Nally Michael

2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2019 

3. Issuer Name and Ticker or Trading Symbol

Merck & Co., Inc. [MRK]

(Last)        (First)        (Middle)

MERCK & CO., INC., 2000 GALLOPING HILL ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
EVP, Chief Marketing Officer /

(Street)

KENILWORTH, NJ 07033       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

1/10/2019 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   100.0000   (1) D    
Common Stock - 401(k) Plan   1365.9535   (2) I   By 401(k)  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit   5/4/2019   (3) 5/4/2021   Common Stock   3896.0000     (4) D    
Restricted Stock Unit   5/10/2019   5/10/2019   Common Stock   1811.0000     (4) D    
Restricted Stock Unit   10/30/2019   (5) 10/30/2021   Common Stock   6862.0000     (4) D    
Restricted Stock Unit   5/5/2020   5/5/2020   Common Stock   2345.0000     (4) D    
Stock Option (right to buy)   5/10/2017   (6) 5/9/2026   Common Stock   7471.0000   $54.6800   D    
Stock Option (right to buy)   5/4/2019   (7) 5/3/2028   Common Stock   27447.0000   $57.7500   D    
Stock Option (right to buy)   5/5/2018   (8) 5/4/2027   Common Stock   14266.0000   $63.9700   D    

Explanation of Responses:
(1)  The original Form 3, filed on January 10, 2019, is being amended by this Form 3 amendment solely to correct the total number of shares beneficially owned by the reporting person to include 100 shares of Merck common stock held in a joint account with the reporting person and the reporting person's parent.
(2)  Includes shares acquired and dividends earned through January 1, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.
(3)  These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
(4)  Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
(5)  These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
(6)  The option vests and becomes exercisable in three equal installments on 5/10/2017, 5/10/2018 and 5/10/2019.
(7)  The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
(8)  The option vests and becomes exercisable in three equal installments on 5/5/2018, 5/5/19 and 5/5/2020.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Nally Michael
MERCK & CO., INC.
2000 GALLOPING HILL ROAD
KENILWORTH, NJ 07033


EVP, Chief Marketing Officer

Signatures
Faye C. Brown as Attorney-in-Fact for Michael Nally 5/7/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Merck (NYSE:MRK)
Graphique Historique de l'Action

1 an : De Juin 2018 à Juin 2019

Plus de graphiques de la Bourse Merck

Merck (NYSE:MRK)
Graphique Intraday de l'Action

Aujourd'hui : Mercredi 26 Juin 2019

Plus de graphiques de la Bourse Merck
Dernières Valeurs Consultées
EU
GLE
Société Gé..
EU
ALU
ALCATEL-LU..
EU
PX1
CAC 40
ORA
Orange
FX
EURUSD
Euro vs Do..
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.


Inscrivez-vous maintenant pour créer votre liste d'actions personnalisée, en streaming.

Les cours EURONEXT (CAC 40, etc. ) et FOREX (les devises) sont en direct si connecté.
NYSE, AMEX, et ASX sont en différé d'environ 20 minutes. Les autres cours sont en différé d'environ 15 minutes.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Conditions Générales

P: V:fr D:20190625 22:06:32